are a normal component of human sperm cells. Antibodies against these protamines develop in 22 to 33 per cent of patients undergoing elective vasectomy. These antibodies, in turn, have been shown to cross-react with medicinal protamines, which are extracted commercially from the testes of salmon and certain other fish. This cross-reactivity against protamines raises the possibility that patients who have undergone elective vasectomy may be at increased risk of an allergic reaction developing if they are later exposed to protamine as a medication. Since medicinal protamines currently enjoy widespread clinical use, this information should be borne in mind by those clinicians using protamine and by urologists when counselling patients concerning elective vasectomy for sterilization.
Protamine is a widely used medication which is administered after certain procedures to reverse heparin-induced anticoagulation.
One would hardly suspect that undergoing an elective vasectomy would place a patient at increased risk of a serious allergic reaction to this medication. Yet, a series of studies from the Netherlands1-3 now provides substantial evidence that, for vasectomized patients, such risk may indeed exist. The following case report is presented to bring further attention to this potential hazard. This patient had previously undergone an elective vasectomy for sterilization in 1967 and had required repeat surgery for sperm granuloma formation in 1975. In assessing the immunologic consequences of the vasectomy, a tray agglutination test (TAT),4 a microimmobilization tesQ5 and an antiprotamine immunofluorescence tests were performed. While results of the immobilization test were negative, the serum showed a sperm-agglutinating antibody titer of 1:1024. And, when swollen sperm heads that had been treated with triton X-100 detergent 1% and diothiothreitol (a reducing agent) were added to serum diluted 1:5 and 1:20, to demonstrate the presence of antiprotamine antibody, one of the most intense immunofluorescent reactions ever recorded in this laboratory occurred.
Comment
Several factors point to a relationship between this patient's history of vasectomy and his subsequent allergic reaction to protamine. First, we do know that vasectomy can lead to formation of systemic antibodies. The studies of several investigator@ have shown that after vasectomy, agglutinating antibodies against spermatozoa develop in 60 per cent or more of the cases. Thus, men who have undergone a vasectomy are at risk of reacting to spermatozoa and their various components.' Protamine is one such component. Protamines are molecules of low molecular weight and consist chiefly of amino acids, most prominently arginine. The compound forms a helix, with arginine moieties facing away from the core (Fig. 1) .8-10 This configuration permits an intimate, spiraling interface with the nuclear DNA moleculer" (Fig. 2) . Protamines are related to nucleohistones. However, while nucleohistones are widely distributed throughout the animal kingdom, it is only in the developing spermatids that these nucleohistones are replaced by nucleoprotamines.2
The protamine used commercially for medication is extracted from sperm cells within the testes of salmon and other fish. These protamines are species specific, but there can be a strong crossover of antigenicity against the protamines of other species. Since in our patient antibodies to the protamine of his own sperm cells as a result of elective vasectomy had already developed, it would seem that subsequent exposure to antigenically similar fish protamine triggered his allergic reaction.
To substantiate this hazard, Samuel2 has undertaken direct immunofluorescence of the sera of 78 men who had undergone elective vasectomy; antibodies against protamine were uncovered in 17 of these patients (22 % ).' In other related studies, antibodies against protamine after vasectomy have been detected in 30 per cent (of 47 patients)3 and 33 per cent (of 71 patients) .7 The observations that these antibodies (1) If these antibodies against human protamine, developed as a result of elective vasectomy, truly increase the risk of an allergic reaction on subsequent exposure to medicinal protamine, the clinical consequences could prove substantial. For instance: (1) patients such as ours who have undergone elective vasectomy might be at higher risk of mild allergic reactions developing on later exposure to protamine as an antiheparin agent; (2) more important, these patients might also be at higher risk of suffering an anaphylactic reaction; and (3) since use of protamine as a heparin antagonist is not limited to open heart surgery, patients exposed to protamine in other cardiovascular surgery, in dialysis, and in many leukophoresis techniques would also be at higher risk of allergic reaction if they had undergone prior vasectomy. Even diabetic patients, following vasectomy, might react adversely to protamine zinc insulin. The exact mechanism by which antibody formation against protamine evolves is not well understood.
Protamine itself does not appear to be antigenic; injections of purified protamines alone do not evoke an antibody response. However, protamines in vivo are intimately bound to the DNA helix (Fig. 2) . Thus it is possible that antibodies are not developed directly against protamine, but rather against the protamine/DNA complex. If this is the case, there may be a risk that in vasectomy patients antibodies will develop not only against protamine, but also against the protamine/DNA complex, and, more specifically, against DNA itself. And, if this is the case, the potential consequences could be far more serious.'.7
Conclusion
The exact clinical consequence of postvasectomy antibodies against protamine remains uncertain.
However, it clearly has been shown that antibodies against human protamine do develop in 22 to 33 per cent of patients undergoing elective vasectomy, and that these antibodies do cross-react with fish protamines now widely used in clinical medicine. This information and the clinical concerns it raises should be borne in mind by clinicians who are using protamine in their practice.
The potential risk should also be kept in mind when urologists counsel their patients concerning elective vasectomy for sterilization.
Technical Publications Editor
Letterman Army Medical Center Presidio of San Francisco, California 94129
